eating disordersMicro + fullBothModerate evidence

Twenty-one women with anorexia, and symptoms that improved for a year

The largest psilocybin study in anorexia so far, and the safety event it reported honestly.

2026Published
Single-blind within-individual pilot studyStudy type
21 peopleSample
What our evidence ratings mean

What they did

Imperial College London gave twenty-one adult women with longstanding anorexia nervosa three dosing sessions over six weeks in a fixed order, starting with a 1mg low-dose control followed by two 25mg sessions, with talk therapy throughout and assessments out to twelve months.

What they found

Eating disorder symptoms and motivation to change both improved significantly, with gains sustained at follow-up, though responses varied considerably from person to person. Twenty of twenty-one completed the active period.

21participants
12 monthsof follow-up

Worth knowing

One participant had two serious safety events, both suicide attempts, in the months after the study ended. Investigators judged them unlikely to be related to the drug, and we report them here because a library that omits them is not a library. The fixed dose order also means order effects cannot be separated from dose effects.

Douglass et al. Psilocybin therapy for adult females with anorexia nervosa, pilot study. The British Journal of Psychiatry, 2026.

Read the source

We include the trials that missed their endpoints alongside the ones that hit. A shelf that only holds good news is a marketing page, not a library.

For education, not medical advice. Every write-up links back to the original source.
Nothing here is a claim that our products treat, cure or prevent any condition. Talk to a doctor before changing anything about your health.